Koss K L, Ponniah S, Jones W K, Grupp I L, Kranias E G
Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, OH 45267-0575, USA.
Circ Res. 1995 Aug;77(2):342-53. doi: 10.1161/01.res.77.2.342.
Phospholamban, the regulator of the Ca2+ pump in cardiac sarcoplasmic reticulum, is differentially expressed between murine atrial and ventricular muscles. Quantitative analyses of RNA isolated from atrial flaps and ventricular apices indicated that the phospholamban gene transcript copy number is 2.5-fold higher in the ventricle compared with the atrium of the FVB/N mouse and 6-fold higher in the ventricle compared with the atrium of the B6D2/F1 mouse strain. These findings were corroborated by in situ hybridization studies of cardiopulmonary sections from both murine strains, and phospholamban transcripts were also observed in pulmonary myocardia of both strains. Analyses of phospholamban transcript levels relative to alpha-myosin heavy chain (alpha-MHC) revealed a 3-fold higher phospholamban abundance in the ventricle compared with the atrium of the FVB/N murine strain. However, the relative mRNA level of Ca(2+)-ATPase (ratio of sarcoplasmic reticulum Ca(2+)-ATPase [SERCA2] to alpha-MHC) in the ventricle was 80% of that in the atrium. Consequently, the relative ratio of phospholamban to SERCA2 mRNA was 4.2-fold lower in the atrium than in the ventricle. The lower transcript ratio of phospholamban to SERCA2 in the atrium was associated with significantly shortened times to half-relaxation (17.40 +/- 0.71 milliseconds for atrium versus 30.58 +/- 2.04 milliseconds for ventricle), assessed in isolated superfused cardiac tissue preparations recorded at maximum length tension. Contraction times, measured as times to peak tension, were also significantly shortened in atrial muscle (27.36 +/- 0.82 milliseconds) compared with ventricular muscle (44.60 +/- 2.55 milliseconds), assessed in the same tissue preparations. These findings suggest that phospholamban gene expression is differentially regulated in murine atrial and ventricular muscles and that this differential expression may be associated with differences in the contractile parameters of these cardiac compartments.
受磷蛋白是心肌肌浆网中钙泵的调节蛋白,在小鼠心房肌和心室肌中存在差异表达。对从小鼠心房肌瓣和心室肌尖分离的RNA进行定量分析表明,在FVB/N小鼠中,心室中受磷蛋白基因转录本的拷贝数比心房高2.5倍;在B6D2/F1小鼠品系中,心室中该转录本拷贝数比心房高6倍。对这两种小鼠品系心肺切片进行的原位杂交研究证实了这些发现,并且在两种品系的肺心肌中也观察到了受磷蛋白转录本。相对于α-肌球蛋白重链(α-MHC)对受磷蛋白转录水平进行分析发现,在FVB/N小鼠品系中,心室中受磷蛋白的丰度比心房高3倍。然而,心室中钙-ATP酶的相对mRNA水平(肌浆网钙-ATP酶[SERCA2]与α-MHC的比值)是心房中的80%。因此,心房中受磷蛋白与SERCA2 mRNA的相对比值比心室低4.2倍。在最大长度张力下记录的离体灌注心脏组织标本中,心房中受磷蛋白与SERCA2较低的转录本比值与半松弛时间显著缩短有关(心房为17.40±0.71毫秒,心室为30.58±2.04毫秒)。在相同组织标本中评估发现,以达到峰值张力的时间来衡量,心房肌的收缩时间(27.36±0.82毫秒)也比心室肌(44.60±2.55毫秒)显著缩短。这些发现表明,受磷蛋白基因表达在小鼠心房肌和心室肌中受到差异调节,并且这种差异表达可能与这些心脏腔室收缩参数的差异有关。